The Recall Desk
Agency classClass IIOur severity:ModerateFDA (Drugs)·D-1394-2012·Announced 2012-07-04

Lloyd Inc Recalls Subpotent Levothroid Levothyroxine Sodium Tablets

Lloyd Inc is recalling 19,039 bottles of Levothroid 75 mcg tablets because the drug tested below the required potency level.

The agency’s classification

FDA (Drugs): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 2/5 (Moderate).

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II, which typically corresponds to a Moderate severity score (2) when no specific hospitalizations or severe injuries are reported in the source text, fitting the criteria for low-risk contamination or minor labeling/potency issues without immediate severe harm.

Plain-English summary

Lloyd Inc is recalling 19,039 bottles of Levothroid (levothyroxine sodium tablets, USP), 75 mcg, 100-count bottles. The product is identified by NDC 0456-1322-01 and Lot No. 1092045. The recall was initiated because the drug was found to be subpotent, meaning it had a low assay at the 6-month test interval.

The affected product was manufactured for Forest Pharmaceuticals, Inc., a subsidiary of Forest Laboratories, Inc., in St. Louis, MO, by Lloyd Pharmaceutical in Shenandoah, Iowa. The recall is classified as Class II by the FDA, indicating a situation where use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.

Consumers who have this specific lot of Levothroid should stop using it and contact their healthcare provider or pharmacist for guidance on obtaining a replacement. The product was distributed nationwide.

The recalled product

Product
Levothroid (levothyroxine sodium tablets, USP), 75 mcg., 100-count bottles, Rx only, NDC 0456-1322-01, Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, Iowa 51601
Manufacturer
Lloyd Inc
Category
Drug — Prescription Medication
Hazard
Affected units
19,039

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • LOT NO.1092045

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 2 recalled by Lloyd Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 2 products in this recall →

Related recalls

Same manufacturer · Lloyd Inc

See all →

Same hazard · subpotent drug

See all →

Similar recalls